Publications by authors named "Xixin Xing"

Claim this Profile
E
Energy status orchestrates YTHDF1 phase separation and tumorigenesis.
Haisheng Yu, Jie Shi, Rongrong He, Xue Zhang, Shuchao Ren, Xixin Xing

Cell Rep· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting the UFL1-PARP1 axis amplifies anti-tumor immunity.
Wenjing Song, Chuan He, Xixin Xing, Gaoshan Xu, Yingmeng Yao

Cell Rep· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting PD-1 post-translational modifications for improving cancer immunotherapy.
Jie Shi, Chuan He, Li Chen, Xixin Xing, Wenyi Wei

Cell Insight· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Author Correction: ERK and USP5 govern PD-1 homeostasis via deubiquitination to modulate tumor immunotherapy.
Xiangling Xiao, Jie Shi, Chuan He, Xia Bu, Yishuang Sun, Xixin Xing

Nat Commun· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting the TRIM21-PD-1 axis potentiates immune checkpoint blockade and CAR-T cell therapy.
Jie Shi, Zijian Zhang, Hsin-Yi Chen, Yingmeng Yao, Shanwen Ke, Xixin Xing

Mol Ther· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The epitranscriptional factor PCIF1 orchestrates CD8 T cell ferroptosis and activation to control antitumor immunity.
Bolin Xiang, Meiling Zhang, Kai Li, Zijian Zhang, Yutong Liu, Xixin Xing

Nat Immunol· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
USP8-governed GPX4 homeostasis orchestrates ferroptosis and cancer immunotherapy.
Haiou Li, Yishuang Sun, Yingmeng Yao, Shanwen Ke, Nannan Zhang, Xixin Xing

Proc Natl Acad Sci U S A· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
UFL1 ablation in T cells suppresses PD-1 UFMylation to enhance anti-tumor immunity.
Chuan He, Xixin Xing, Hsin-Yi Chen, Minling Gao, Jie Shi, Yujie Xing

Mol Cell· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
ERK and USP5 govern PD-1 homeostasis via deubiquitination to modulate tumor immunotherapy.
Xiangling Xiao, Jie Shi, Chuan He, Xia Bu, Yishuang Sun, Xixin Xing

Nat Commun· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis